# Foghorn Therapeutics Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:abe5f206-0c48-4e17-a0e6-c0141088b280 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/foghorn-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 17 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:53:03.361372+00:00 | | Last reviewed | 2026-10-16T13:53:03.361372+00:00 | ## Identity - Legal name: Foghorn Therapeutics Inc. - Display name: Foghorn Therapeutics Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T03:43:42.507429+00:00 | | Completeness | 0.409 | | Record Quality | 0.848 | | Directors | 9 | | Committees | 1 | | Governance events | 12 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Adrian Gottschalk: Director. Status: current. Independent: false. Since: 2017-01-01. claim_id=alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:5 - Balkrishan Simba Gill, Ph.D.: Director. Status: current. Independent: true. Since: 2017-01-01. claim_id=alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:6 - Douglas G. Cole, M.D.: Director. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:7 - Ian F. Smith: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:8 - Michael Mendelsohn, M.D.: Director. Status: current. Independent: true. Since: 2017-01-01. claim_id=alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:9 - Neil J. Gallagher, M.D., Ph.D.: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:10 - Scott Biller, Ph.D.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:11 - Stuart Duty: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (member). claim_id=alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:12 - Thomas J. Lynch, Jr., M.D.: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:13 ## Committees - Audit (audit). Chair: NOT_PUBLISHED. Members: Stuart Duty (member, current). committee_id=alpha:committee:foghorn-therapeutics-inc:audit ## Executive leadership - Adrian Gottschalk: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:14 - Ryan Maynard: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:15 ## Governance events - CEO_CHANGED: Adrian Gottschalk executive of Foghorn Therapeutics Inc., effective 2026-03-11. Effective: 2026-03-11. Detected: 2026-10-16T13:53:03.361372+00:00. event_id=alpha:event:transition:3a1i4817dgyau - CFO_CHANGED: Ryan Maynard executive of Foghorn Therapeutics Inc., effective 2026-03-11. Effective: 2026-03-11. Detected: 2026-10-16T13:53:03.361372+00:00. event_id=alpha:event:transition:13df8y917v8u93 - DIRECTOR_APPOINTED: Neil J. Gallagher, M.D., Ph.D. seat on Foghorn Therapeutics Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:53:03.361372+00:00. event_id=alpha:event:transition:1qu2dimbp1y9e - DIRECTOR_APPOINTED: Stuart Duty seat on Foghorn Therapeutics Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:53:03.361372+00:00. event_id=alpha:event:transition:fp3shs1lk9lxs - COMMITTEE_MEMBER_ADDED: Stuart Duty member of Audit, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:53:03.361372+00:00. event_id=alpha:event:transition:lky6t839jl0 - DIRECTOR_APPOINTED: Thomas J. Lynch, Jr., M.D. seat on Foghorn Therapeutics Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T13:53:03.361372+00:00. event_id=alpha:event:transition:uj9liy1199km6 - DIRECTOR_APPOINTED: Ian F. Smith seat on Foghorn Therapeutics Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:03.361372+00:00. event_id=alpha:event:transition:13i0wgr1uu41uf - DIRECTOR_APPOINTED: Scott Biller, Ph.D. seat on Foghorn Therapeutics Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:03.361372+00:00. event_id=alpha:event:transition:ual1pq1lt5ssu - DIRECTOR_APPOINTED: Adrian Gottschalk seat on Foghorn Therapeutics Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:53:03.361372+00:00. event_id=alpha:event:transition:e0pu8x16up0sz - DIRECTOR_APPOINTED: Balkrishan Simba Gill, Ph.D. seat on Foghorn Therapeutics Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:53:03.361372+00:00. event_id=alpha:event:transition:1qeakes13veg7g - DIRECTOR_APPOINTED: Michael Mendelsohn, M.D. seat on Foghorn Therapeutics Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:53:03.361372+00:00. event_id=alpha:event:transition:197p5npube05b - DIRECTOR_APPOINTED: Douglas G. Cole, M.D. seat on Foghorn Therapeutics Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:53:03.361372+00:00. event_id=alpha:event:transition:msofc11uf3giz ## Scoped resources - `alpha://company/foghorn-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record - `alpha://company/foghorn-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=identity - `alpha://company/foghorn-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/foghorn-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=board - `alpha://company/foghorn-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=committees - `alpha://company/foghorn-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=leadership - `alpha://company/foghorn-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=ownership - `alpha://company/foghorn-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=financials - `alpha://company/foghorn-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/foghorn-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=compensation - `alpha://company/foghorn-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=governance - `alpha://company/foghorn-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/foghorn-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=audit - `alpha://company/foghorn-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=legal - `alpha://company/foghorn-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=risk - `alpha://company/foghorn-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=cyber - `alpha://company/foghorn-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/foghorn-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=agents - `alpha://company/foghorn-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/foghorn-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=events - `alpha://company/foghorn-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=relationships - `alpha://company/foghorn-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=assessments - `alpha://company/foghorn-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:stuart-duty","name":"Stuart Duty"},"source_id":"board_seats"}` ## Leadership - Adrian Gottschalk: Director. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:5. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:145f0fcaf5743db299db9c021c971c3884804753bb3f5287a80b3a528517d9a5. - Balkrishan Simba Gill, Ph.D.: Director. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:6. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:145f0fcaf5743db299db9c021c971c3884804753bb3f5287a80b3a528517d9a5. - Douglas G. Cole, M.D.: Director. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:7. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:145f0fcaf5743db299db9c021c971c3884804753bb3f5287a80b3a528517d9a5. - Ian F. Smith: Director. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:145f0fcaf5743db299db9c021c971c3884804753bb3f5287a80b3a528517d9a5. - Michael Mendelsohn, M.D.: Director. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:9. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:145f0fcaf5743db299db9c021c971c3884804753bb3f5287a80b3a528517d9a5. - Neil J. Gallagher, M.D., Ph.D.: Director. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:10. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:145f0fcaf5743db299db9c021c971c3884804753bb3f5287a80b3a528517d9a5. - Scott Biller, Ph.D.: Director. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:11. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:145f0fcaf5743db299db9c021c971c3884804753bb3f5287a80b3a528517d9a5. - Stuart Duty: Director, Audit. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:12. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:145f0fcaf5743db299db9c021c971c3884804753bb3f5287a80b3a528517d9a5. - Thomas J. Lynch, Jr., M.D.: Director. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:13. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:145f0fcaf5743db299db9c021c971c3884804753bb3f5287a80b3a528517d9a5. - Adrian Gottschalk: President, Chief Executive Officer and Director. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:14. Valid from: 2026-03-11. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e5263bb4704c9832e154c2add93f87526626c0a677eab492cc670a49253ae051. - Ryan Maynard: Chief Financial Officer. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:leadership_role:15. Valid from: 2026-03-11. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c3af8a8aedb8f749f0ad6785d5ddfa673118d01e8d2161bf0b61d68943acb370. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair not stated; Members Stuart Duty. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:fd275246c98f62f221c1c36e93367e032a56980c072b55f2b231524b02c88ec6. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Foghorn Therapeutics Inc.. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:149bc840a2ebf669ae24004bb8aea1b015e123c463bb320cdc951714c7ab47d9. ## Entity Status - Public listing published. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:149bc840a2ebf669ae24004bb8aea1b015e123c463bb320cdc951714c7ab47d9. ## Published Fact - US. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:149bc840a2ebf669ae24004bb8aea1b015e123c463bb320cdc951714c7ab47d9. ## Committee Appointment - Stuart Duty: member, Audit. Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:fd275246c98f62f221c1c36e93367e032a56980c072b55f2b231524b02c88ec6. ## Security Listing - FHTX (NASDAQ). Claim: alpha:claim:company:abe5f206-0c48-4e17-a0e6-c0141088b280:security_listing:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:149bc840a2ebf669ae24004bb8aea1b015e123c463bb320cdc951714c7ab47d9. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:149bc840a2ebf669ae24004bb8aea1b015e123c463bb320cdc951714c7ab47d9: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/foghorn-therapeutics-inc). - alpha:projection-evidence:document:145f0fcaf5743db299db9c021c971c3884804753bb3f5287a80b3a528517d9a5: [Foghorn Therapeutics Inc. DEF 14A 2025-05-05](https://www.sec.gov/Archives/edgar/data/1822462/000119312525112091/d875647ddef14a.htm). - alpha:projection-evidence:document:e5263bb4704c9832e154c2add93f87526626c0a677eab492cc670a49253ae051: [FHTX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1822462/000162828026016814/fhtx-20251231.htm). - alpha:projection-evidence:document:c3af8a8aedb8f749f0ad6785d5ddfa673118d01e8d2161bf0b61d68943acb370: [FHTX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1822462/000162828026016814/fhtx-20251231.htm). - alpha:projection-evidence:fd275246c98f62f221c1c36e93367e032a56980c072b55f2b231524b02c88ec6: [Audit](https://www.sec.gov/Archives/edgar/data/1822462/000119312525112091/d875647ddef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/foghorn-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/foghorn-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/foghorn-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/foghorn-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T03:43:42.283125+00:00; recorded 2026-10-17T03:43:42.283125+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.